Ausgabe 1/2024
Inhalt (20 Artikel)
Association between prediabetes and breast cancer: a comprehensive meta-analysis
Praneeth Reddy Keesari, Akhil Jain, Narendranath Reddy Ganampet, Guna Sowmya Durga Subhasri, Samuel Edusa, Zainab Muslehuddin, Nyein Wint Yee Theik, Spandana Palisetti, Divya Salibindla, Pritika Singh Manaktala, Rupak Desai
Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer
Anupama Praveen Kumar, Diego Vicente, Jianfang Liu, Praveen-Kumar Raj-Kumar, Brenda Deyarmin, Xiaoying Lin, Craig D. Shriver, Hai Hu
Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients
Mieke C. Zwager, Iris Holt-Kedde, Hetty Timmer-Bosscha, Geertruida H. de Bock, Paul M. N. Werker, Carolien P. Schröder, Bert van der Vegt, Marlous Arjaans
Analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and offers alternatives for novel assessment of clinical trials
Celine Yeh, Mengxi Zhou, Neil Bapodra, Dawn Hershman, Edward Espinal, Marina Moran, Maria Rivero, Antonio Tito Fojo, Susan E. Bates
Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer
Melissa K. Accordino, Shing Lee, Cheng Shiun Leu, Bruce Levin, Meghna S. Trivedi, Katherine D. Crew, Kevin Kalinsky, Rohit Raghunathan, Khadija Faheem, Erik Harden, Alessandra Taboada, Beatriz Desanti de Oliveira, Elisabeth Larson, Lauren Franks, Erin Honan, Cynthia Law, Dawn L. Hershman
The effects of contemporary treatment of DCIS on the risk of developing an ipsilateral invasive Breast cancer (iIBC) in the Dutch population
Sena Alaeikhanehshir, Renée S.J.M. Schmitz, Alexandra W. van den Belt-Dusebout, Frederieke H. van Duijnhoven, Ellen Verschuur, Maartje van Seijen, Michael Schaapveld, Esther H. Lips, Jelle Wesseling
Association between body mass index and outcomes after autologous breast reconstruction: a nationwide inpatient database study in Japan
Ryo Karakawa, Takaaki Konishi, Hidehiko Yoshimatsu, Yohei Hashimoto, Hiroki Matsui, Kiyohide Fushimi, Tomoyuki Yano, Hideo Yasunaga
Incidence and risk factors of hypothyroidism after treatment for early breast cancer: a population-based cohort study
Evangelos Digkas, Daniel Robert Smith, Anna-Karin Wennstig, Alexios Matikas, Eva Tegnelius, Antonios Valachis
Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis
Huiyue Li, Jennifer K. Plichta, Kan Li, Yizi Jin, Samantha M. Thomas, Fei Ma, Li Tang, Qingyi Wei, You-Wen He, Qichen Chen, Yuanyuan Guo, Yueping Liu, Jian Zhang, Sheng Luo
Patterns of chemotherapy receipt among patients with hormone receptor-positive, HER2-negative breast cancer
Linnea T. Olsson, Alina M. Hamilton, Sarah C. Van Alsten, Jennifer L. Lund, Til Stürmer, Hazel B. Nichols, Katherine E. Reeder-Hayes, Melissa A. Troester
Superparamagnetic iron oxide (SPIO) for axillary mapping in patients with ductal carcinoma in situ undergoing mastectomy: single-institution experience
Jamin Kweku Addae, Raeshell Sharawn Sweeting, Ingrid Marie Meszoely, Rachel Louise McCaffrey, Rondi Marie Kauffmann, Mark Carlton Kelley, Ana Magdalena Grau, Kelly Hewitt
A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer
Erica L. Mayer, Nabihah Tayob, Siyang Ren, Jennifer J. Savoie, David R. Spigel, Howard A. Burris III, Paula D. Ryan, Lyndsay N. Harris, Eric P. Winer, Harold J. Burstein
Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene
Shaymaa M. M. Yahya, Heba K. Nabih, Ghada H. Elsayed, Shimaa Ibrahim Abdelmenym Mohamed, Asmaa M. Elfiky, Sohair M. Salem
Breast cancers in monoallelic MUTYH germline mutation carriers have clinicopathological features overlapping with those in BRCA1 germline mutation carriers
Aysenur Keske, Paul Weisman, Monica Ospina-Romero, Prachi Raut, Kelcy Smith-Simmer, Anna L. Zakas, Christopher Flynn, Jin Xu
FTO is a major genetic link between breast cancer, obesity, and diabetes
Morteza Gholami
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants
Christopher J. Schwartz, Nikka Khorsandi, Amie Blanco, Rita A. Mukhtar, Yunn-Yi Chen, Gregor Krings
Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study
Deanna Blansky, Norin Ansari, Lucy Gao, Ethan S. Sokol, Smruthy Sivakumar, Richard S.P. Huang, Maureen Pelletier, Mia Levy, Dean Pavlick, Natalie Danziger, Jeffrey S Ross, Maryam Lustberg, Mariya Rozenblit
“Enhancing survival outcomes through breast-conserving therapy in ipsilateral breast tumor recurrence: insights into metastasis and treatment strategies”
Kefah Mokbel, Munaser Alamoodi
Northern origin of the BRCA2 c.5286 T > G founder allele
Grigory A. Yanus, Anna P. Sokolenko, Evgeny N. Imyanitov